References: Disclaimer: Please note the intention of the information provided is for reference only
GLP-1 receptor agonist medications have transformed weight management for people struggling with obesity and metabolic disease
Key approved indications include: Type 2 diabetes mellitus management (Mounjaro) Chronic weight management in obesity or overweight with comorbidities (Zepbound) Use as adjunct to lifestyle modification (diet and exercise) It is critical to recognize that tirzepatide has no FDA approval for the treatment, prevention, or management of autoimmune diseases
In the US, there are nearly 30,000 patients under 20 living with T2D with 5,300 new cases diagnosed each year, according to the US Centers for Disease Control and Prevention and recent research
Baseline skin condition influences retention potential where users treating specific correctable issues (scarring, hyperpigmentation, acute damage) tend maintaining improvements better than users seeking general anti-aging effects
Pancreatology 14 , 490496 (2014)
